Appendix cancer webinars and events.
Expert-led sessions on diagnosis, treatment, HIPEC, PIPAC, clinical trials, caregiving, and survivorship, live and on demand. Free for patients, caregivers, and advocates.
Appendix cancer webinars and events are where knowledge meets community in the fight against this rare disease. APPENDICURE produces and curates expert-led sessions designed to inform, support, and connect patients, caregivers, and advocates from around the world.
Whether you are newly diagnosed and trying to understand the basics or a long-time advocate tracking the latest research, you get direct access to the surgeons, oncologists, researchers, and survivors shaping the field. Live sessions let you ask questions in real time. Recorded sessions are free to watch anytime on our YouTube channel. See what is coming up next under Upcoming Webinars above.
Upcoming Webinars
Save your seat. These sessions are free and open to all.
Metformin in Pseudomyxoma Peritonei Secondary to Appendiceal Mucinous Neoplasms
Dr. Oliver S. Eng, University of California, Irvine. A live Q&A on metformin therapy in pseudomyxoma peritonei (PMP) from appendiceal mucinous neoplasms (AMNs).
Zoom · RSVPPast appendix cancer webinars on demand
Watch every APPENDICURE session anytime on our YouTube channel.
Past Appendix Cancer Webinars
Recordings of every session. Free, no signup required.
August 21, 2026
Appendix Cancer Treatment Update: GNAS, KRAS, and CDK4/6 Inhibitors
Dr. Andrew Lowy, UC San Diego Moores Cancer Center, on what GNAS and KRAS mutations mean for treatment decisions and where CDK4/6 inhibitors fit. Covers high-grade appendiceal adenocarcinoma, goblet cell adenocarcinoma, signet ring cell, and low-grade mucinous disease, with a live Q&A from the APPENDICURE community.
August 17, 2026
Fighting Insurance Denials in Appendix Cancer
Sally Nix and Matt Toresco, co-founders of We The Patients, on what to do when a claim is denied: your right to a written denial, requesting your full claim file, asking for the reviewer’s NPI number, getting a peer-to-peer scheduled, and demanding a 72-hour expedited external review. Includes a live Q&A on HIPEC denied as “experimental” and denials written against colorectal cancer guidelines.
June 17, 2026
JP Shen, MD: Quarterly Appendiceal Cancer Updates
Dr. JP Shen, MD Anderson Cancer Center, with a quarterly update for the APPENDICURE community on the latest in appendiceal cancer research, treatment, and clinical trials, plus a live Q&A.
April 25, 2026
Honoring Audrey, Advancing Hope
Sean Hepburn Ferrer on his mother Audrey Hepburn, her legacy, and his ongoing appendix cancer advocacy, with a live audience Q&A.
April 23, 2026
A New Trial for High-Grade Appendiceal Cancer, GCA, Signet Ring
Dr. Kiran Turaga, Yale Medicine, on a new HIPEC trial for high-grade appendiceal cancers, goblet cell adenocarcinoma, and signet ring cell variants.
UC San Diego Moores Cancer Center
Appendiceal Cancer Research & Treatment
Dr. Andrew Lowy, UC San Diego Moores Cancer Center, a leading surgical oncologist in appendiceal and peritoneal surface cancers, on the latest in research and care.
Allegheny Health Network
Peritoneal Carcinomatosis Research
Shannon Altpeter and Dr. Patrick Wagner share a research study aimed at improving treatment of PC, also known as pseudomyxoma peritonei (PMP).
January 21, 2026
Updates on the Study of Appendix Cancer
Dr. JP Shen, MD Anderson Cancer Center, on the latest appendix cancer research and what it means for patients.
November 8, 2025
From Cardiac Surgeon to Survivor
Dr. Steven Himmelstein shares his journey from cardiac surgeon to appendix cancer patient to long-term survivor.
October 14, 2025
Memorial Sloan Kettering’s LAMN Clinic
An inside look at the dedicated LAMN (Low-grade Appendiceal Mucinous Neoplasm) clinic at Memorial Sloan Kettering.
August 4, 2025
The ICARuS Trial Findings
Dr. Nash, Memorial Sloan Kettering, on findings from the Intraperitoneal Chemotherapy After Cytoreductive Surgery (ICARuS) trial.
May 23, 2025
HIPEC: Hyperthermic Intraperitoneal Chemotherapy
Dr. Armando Sardi, Mercy Hospital Baltimore, explains HIPEC: what it is, who it’s for, and what to expect.
MD Anderson Cancer Center
Live Q&A and New GCA Study
Dr. JP Shen on a new study of Goblet Cell Adenocarcinoma (GCA) with a live audience Q&A.
Webinars from Our Partner Organizations
Trusted appendix cancer content from organizations we collaborate with.
Partner Webinar
Appendix Cancer Education from a Partner Organization
Expert insights and patient education from one of APPENDICURE’s partner organizations advancing rare cancer awareness.
Partner Webinar
Appendix Cancer Insights from a Partner Organization
Additional perspectives and education from a trusted partner in the appendix cancer community.
Why APPENDICURE Hosts Webinars and Events
Because connection fuels courage, and rare cancer education shouldn’t be locked behind paywalls.
Appendix cancer is rare enough that most patients and caregivers will never meet another person with the same diagnosis in person. Reliable, plain-language education from specialists is hard to come by, and harder still to verify. APPENDICURE webinars and events exist to close that gap. Every session features clinicians, researchers, or survivors with deep knowledge of appendiceal cancer, and every recording stays free and publicly available afterward.
Topics rotate based on what our community is asking about. Recent appendix cancer webinars have covered GNAS and KRAS mutations and CDK4/6 inhibitors, fighting insurance denials, HIPEC and CRS surgery, the ICARuS trial findings, the role of AI in cancer research, MSK’s dedicated LAMN clinic, new high-grade appendiceal cancer trials, and survivor stories. Sessions range from clinician-led talks to survivor stories and live Q&A with the specialists treating this disease. If there is a topic you would like to see covered, send us a note. We build the schedule around what matters most to patients and caregivers.
Everything is free. No paywall, no required registration to watch recordings, and no medical advice that should replace what your care team tells you. These sessions are designed to inform, so you can have better conversations with your own physicians and feel less alone along the way.
From the APPENDICURE Blog
Latest research, patient stories, and rare cancer education.
Appendix Cancer AI: How KRAS Drug Discovery Could Change Treatment
Read more → Survival DataMucinous Appendiceal Adenocarcinoma Survival, Part II
Read more → New StudyPseudomyxoma Peritonei PCI: When the Number Stops Telling the Whole Story
Read more → ResearchAppendix Cancer m6A: What the PACE Study Reveals About Hidden Biology
Read more → GuidelinesAppendix Cancer Guidelines and the PSM Consortium’s Trainee-Led Update Model
Read more → SurgeryCRS-HIPEC Surgeon Volume: Why the Whole Team Matters
Read more →Share APPENDICURE
Help spread the word about appendix cancer awareness, research, and community.
Never miss a webinar or event.
Get notified when new appendix cancer webinars and events are scheduled.
APPENDICURE never shares your email. Unsubscribe anytime.